Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Clinton Foundation Makes Huge HIV/AIDS Buy From India’s Cipla

This article was originally published in PharmAsia News

Executive Summary

The foundation of former U.S. President Bill Clinton has made a large buy of pediatric antiretroviral drugs from India's Cipla. The drugs are to be distributed by the Clinton Foundation in 62 developing countries with most of the children with HIV/AIDS. A Cipla physician said the firm was chosen in part because it is one of only a few companies with a pediatric dosage of the AIDS drug. Of the 22 retrovirals approved by the U.S. FDA, only five are either available in a pediatric dosage or approved for use in children. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC069272

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel